HEADER CELL ADHESION 22-APR-08 2JJT TITLE STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL REGULATORY TITLE 2 PROTEIN (SIRP) ALPHA COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N-TERMINAL ECTODOMAIN, RESIDUES 31-148; COMPND 5 SYNONYM: SIRP ALPHA, SHP SUBSTRATE 1, SHPS-1, INHIBITORY RECEPTOR COMPND 6 SHPS-1, SIGNAL REGULATORY PROTEIN ALPHA-1, SIRP-ALPHA-1, SIRP-ALPHA- COMPND 7 2, SIRP-ALPHA- 3, MYD-1 ANTIGEN, BRAIN IG-LIKE MOLECULE WITH COMPND 8 TYROSINE- BASED ACTIVATION MOTIFS, BIT, MACROPHAGE FUSION RECEPTOR, COMPND 9 P84, CD172A ANTIGEN; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: LEUKOCYTE SURFACE ANTIGEN CD47; COMPND 13 CHAIN: C, D; COMPND 14 FRAGMENT: IMMUNOGLOBULIN-SUPERFAMILY ECTODOMAIN, RESIDUES 19-136; COMPND 15 SYNONYM: CD47, INTEGRIN-ASSOCIATED PROTEIN, IAP, ANTIGENIC SURFACE COMPND 16 DETERMINANT PROTEIN OA3, PROTEIN MER6; COMPND 17 ENGINEERED: YES; COMPND 18 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: LEC3.2.8.1; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: CHO; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PEE14; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 17 EXPRESSION_SYSTEM_VARIANT: LEC3.2.8.1; SOURCE 18 EXPRESSION_SYSTEM_CELL_LINE: CHO; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PEE14 KEYWDS SIGNAL REGULATORY PROTEIN ALPHA, IMMUNOGLOBULIN SUPERFAMILY, KEYWDS 2 TRANSMEMBRANE, PHOSPHOPROTEIN, PAIRED RECEPTOR, POLYMORPHISM, KEYWDS 3 GLYCOPROTEIN, CELL ADHESION, PYRROLIDONE CARBOXYLIC ACID, KEYWDS 4 ALTERNATIVE SPLICING, IMMUNOGLOBULIN DOMAIN, SIRP, CD47, SIRPA, KEYWDS 5 MEMBRANE, SH3-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR D.HATHERLEY,S.C.GRAHAM,J.TURNER,K.HARLOS,D.I.STUART,A.N.BARCLAY REVDAT 8 16-OCT-24 2JJT 1 REMARK REVDAT 7 13-DEC-23 2JJT 1 HETSYN REVDAT 6 29-JUL-20 2JJT 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE REVDAT 5 11-MAR-20 2JJT 1 SEQRES REVDAT 4 03-APR-19 2JJT 1 SOURCE REVDAT 3 13-MAR-19 2JJT 1 TITLE JRNL REMARK LINK REVDAT 2 24-FEB-09 2JJT 1 VERSN REVDAT 1 05-AUG-08 2JJT 0 JRNL AUTH D.HATHERLEY,S.C.GRAHAM,J.TURNER,K.HARLOS,D.I.STUART, JRNL AUTH 2 A.N.BARCLAY JRNL TITL PAIRED RECEPTOR SPECIFICITY EXPLAINED BY STRUCTURES OF JRNL TITL 2 SIGNAL REGULATORY PROTEINS ALONE AND COMPLEXED WITH CD47. JRNL REF MOL. CELL V. 31 266 2008 JRNL REFN ISSN 1097-4164 JRNL PMID 18657508 JRNL DOI 10.1016/J.MOLCEL.2008.05.026 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 18293 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.238 REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.288 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 989 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1306 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2920 REMARK 3 BIN FREE R VALUE SET COUNT : 59 REMARK 3 BIN FREE R VALUE : 0.3500 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3506 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 43 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.62000 REMARK 3 B22 (A**2) : 4.40000 REMARK 3 B33 (A**2) : -1.78000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.542 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.301 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.256 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 22.284 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.921 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.875 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3667 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2439 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4985 ; 1.193 ; 1.986 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5947 ; 0.821 ; 3.003 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 453 ; 6.564 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 145 ;38.081 ;24.828 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 605 ;12.749 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;14.203 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 595 ; 0.074 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4097 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 697 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 507 ; 0.168 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2313 ; 0.194 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1699 ; 0.170 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1955 ; 0.091 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 107 ; 0.155 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 14 ; 0.133 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 44 ; 0.276 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 7 ; 0.126 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2457 ; 0.322 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3689 ; 0.465 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1532 ; 0.842 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1296 ; 1.266 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 2 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 9 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 4 A 23 1 REMARK 3 1 B 4 B 23 1 REMARK 3 2 A 24 A 26 3 REMARK 3 2 B 24 B 26 3 REMARK 3 3 A 27 A 39 1 REMARK 3 3 B 27 B 39 1 REMARK 3 4 A 48 A 52 1 REMARK 3 4 B 48 B 52 1 REMARK 3 5 A 59 A 60 1 REMARK 3 5 B 59 B 60 1 REMARK 3 6 A 61 A 62 3 REMARK 3 6 B 61 B 62 3 REMARK 3 7 A 63 A 67 1 REMARK 3 7 B 63 B 67 1 REMARK 3 8 A 68 A 68 3 REMARK 3 8 B 68 B 68 3 REMARK 3 9 A 69 A 113 1 REMARK 3 9 B 69 B 113 1 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 1169 ; 0.03 ; 0.05 REMARK 3 LOOSE POSITIONAL 1 A (A): 40 ; 0.83 ; 5.00 REMARK 3 TIGHT THERMAL 1 A (A**2): 1169 ; 0.05 ; 0.50 REMARK 3 LOOSE THERMAL 1 A (A**2): 40 ; 0.64 ; 10.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : C D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 13 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 C 1 C 11 1 REMARK 3 1 D 1 D 11 1 REMARK 3 2 C 12 C 19 3 REMARK 3 2 D 12 D 19 3 REMARK 3 3 C 20 C 30 1 REMARK 3 3 D 20 D 30 1 REMARK 3 4 C 31 C 32 3 REMARK 3 4 D 31 D 32 3 REMARK 3 5 C 33 C 54 1 REMARK 3 5 D 33 D 54 1 REMARK 3 6 C 55 C 55 3 REMARK 3 6 D 55 D 55 3 REMARK 3 7 C 56 C 83 1 REMARK 3 7 D 56 D 83 1 REMARK 3 8 C 84 C 84 3 REMARK 3 8 D 84 D 84 3 REMARK 3 9 C 85 C 92 1 REMARK 3 9 D 85 D 92 1 REMARK 3 10 C 93 C 93 3 REMARK 3 10 D 93 D 93 3 REMARK 3 11 C 94 C 96 1 REMARK 3 11 D 94 D 96 1 REMARK 3 12 C 97 C 97 3 REMARK 3 12 D 97 D 97 3 REMARK 3 13 C 98 C 114 1 REMARK 3 13 D 98 D 114 1 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 2 C (A): 1401 ; 0.03 ; 0.05 REMARK 3 LOOSE POSITIONAL 2 C (A): 91 ; 1.44 ; 5.00 REMARK 3 TIGHT THERMAL 2 C (A**2): 1401 ; 0.06 ; 0.50 REMARK 3 LOOSE THERMAL 2 C (A**2): 91 ; 0.64 ; 10.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 3 A 115 REMARK 3 ORIGIN FOR THE GROUP (A): -4.0757 -16.1226 -38.2919 REMARK 3 T TENSOR REMARK 3 T11: -0.1426 T22: 0.0147 REMARK 3 T33: -0.0909 T12: 0.0581 REMARK 3 T13: -0.0133 T23: -0.0787 REMARK 3 L TENSOR REMARK 3 L11: 3.0327 L22: 3.0292 REMARK 3 L33: 5.4104 L12: 1.5186 REMARK 3 L13: -1.8208 L23: 1.2215 REMARK 3 S TENSOR REMARK 3 S11: -0.0211 S12: -0.3348 S13: 0.0541 REMARK 3 S21: 0.1699 S22: 0.2360 S23: -0.0604 REMARK 3 S31: 0.2446 S32: 0.1196 S33: -0.2149 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 2 B 115 REMARK 3 ORIGIN FOR THE GROUP (A): 13.8602 -14.8264 -21.9409 REMARK 3 T TENSOR REMARK 3 T11: -0.1052 T22: -0.0266 REMARK 3 T33: -0.0937 T12: -0.0604 REMARK 3 T13: 0.0457 T23: -0.0713 REMARK 3 L TENSOR REMARK 3 L11: 5.7643 L22: 2.6731 REMARK 3 L33: 5.3597 L12: -0.5500 REMARK 3 L13: -2.4354 L23: -0.6759 REMARK 3 S TENSOR REMARK 3 S11: -0.3086 S12: 0.7178 S13: -0.4818 REMARK 3 S21: -0.1137 S22: 0.2465 S23: -0.1926 REMARK 3 S31: 0.4220 S32: -0.1562 S33: 0.0621 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 1 C 115 REMARK 3 ORIGIN FOR THE GROUP (A): 20.2670 -12.7130 -50.1739 REMARK 3 T TENSOR REMARK 3 T11: -0.0922 T22: -0.0396 REMARK 3 T33: -0.1014 T12: -0.0585 REMARK 3 T13: 0.0308 T23: -0.0352 REMARK 3 L TENSOR REMARK 3 L11: 6.3671 L22: 0.9314 REMARK 3 L33: 2.0994 L12: -0.5627 REMARK 3 L13: -0.6866 L23: 0.2440 REMARK 3 S TENSOR REMARK 3 S11: -0.0618 S12: -0.0893 S13: -0.0078 REMARK 3 S21: -0.0287 S22: -0.0224 S23: -0.0454 REMARK 3 S31: -0.0134 S32: 0.4001 S33: 0.0843 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 1 D 115 REMARK 3 ORIGIN FOR THE GROUP (A): -9.8945 -10.6325 -10.3089 REMARK 3 T TENSOR REMARK 3 T11: -0.1082 T22: -0.2033 REMARK 3 T33: -0.1582 T12: 0.0082 REMARK 3 T13: 0.0222 T23: 0.0138 REMARK 3 L TENSOR REMARK 3 L11: 4.6133 L22: 1.2348 REMARK 3 L33: 3.2757 L12: 0.9536 REMARK 3 L13: -0.9421 L23: -0.5443 REMARK 3 S TENSOR REMARK 3 S11: -0.1102 S12: 0.3007 S13: -0.0011 REMARK 3 S21: 0.0095 S22: 0.0644 S23: 0.1352 REMARK 3 S31: 0.2217 S32: -0.2965 S33: 0.0459 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. B VALUES INCLUDE TLS CONTRIBUTIONS. REMARK 4 REMARK 4 2JJT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-APR-08. REMARK 100 THE DEPOSITION ID IS D_1290036007. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-NOV-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.873 REMARK 200 MONOCHROMATOR : SI(111) MONOCHROMATOR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19339 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.19000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.45 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 6.70 REMARK 200 R MERGE FOR SHELL (I) : 0.57000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2JJS CHAINS A AND C REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 NL SIRP ALPHA / CD47 COMPLEX (1:1 REMARK 280 RATIO, EACH PROTEIN AT APPROX. 0.375 UM) PLUS 100 NL RESERVOIR REMARK 280 (0.1 M CITRATE PH 5.0, 30% W/V PEG 3000) EQUILIBRATED AGAINST 95 REMARK 280 UL OF RESERVOIR AT 5 C., TEMPERATURE 278K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.81000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.51000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.86000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.51000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.81000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.86000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 2240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14060 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 2200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN C, CYS 33 TO GLY REMARK 400 ENGINEERED RESIDUE IN CHAIN D, CYS 33 TO GLY REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 1 REMARK 465 GLU A 2 REMARK 465 LYS A 116 REMARK 465 PRO A 117 REMARK 465 SER A 118 REMARK 465 THR A 119 REMARK 465 ARG A 120 REMARK 465 HIS A 121 REMARK 465 HIS A 122 REMARK 465 HIS A 123 REMARK 465 HIS A 124 REMARK 465 HIS A 125 REMARK 465 HIS A 126 REMARK 465 GLU B 1 REMARK 465 LYS B 116 REMARK 465 PRO B 117 REMARK 465 SER B 118 REMARK 465 THR B 119 REMARK 465 ARG B 120 REMARK 465 HIS B 121 REMARK 465 HIS B 122 REMARK 465 HIS B 123 REMARK 465 HIS B 124 REMARK 465 HIS B 125 REMARK 465 HIS B 126 REMARK 465 VAL C 116 REMARK 465 SER C 117 REMARK 465 TRP C 118 REMARK 465 SER C 119 REMARK 465 THR C 120 REMARK 465 ARG C 121 REMARK 465 HIS C 122 REMARK 465 HIS C 123 REMARK 465 HIS C 124 REMARK 465 HIS C 125 REMARK 465 HIS C 126 REMARK 465 HIS C 127 REMARK 465 VAL D 116 REMARK 465 SER D 117 REMARK 465 TRP D 118 REMARK 465 SER D 119 REMARK 465 THR D 120 REMARK 465 ARG D 121 REMARK 465 HIS D 122 REMARK 465 HIS D 123 REMARK 465 HIS D 124 REMARK 465 HIS D 125 REMARK 465 HIS D 126 REMARK 465 HIS D 127 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 56 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 65 CG CD OE1 OE2 REMARK 470 ARG A 114 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 2 CG CD OE1 OE2 REMARK 470 GLU B 70 CG CD OE1 OE2 REMARK 470 ARG B 114 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 84 CG CD CE NZ REMARK 470 ARG C 114 CG CD NE CZ NH1 NH2 REMARK 470 ARG D 114 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU C 101 -104.12 51.60 REMARK 500 LEU D 101 -107.19 50.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2JJS RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL RECEPTOR REMARK 900 PEPTIDE (SIRP) ALPHA REMARK 900 RELATED ID: 2VSC RELATED DB: PDB REMARK 900 STRUCTURE OF THE IMMUNOGLOBULIN-SUPERFAMILY ECTODOMAIN OF HUMAN CD47 REMARK 900 RELATED ID: 2UV3 RELATED DB: PDB REMARK 900 STRUCTURE OF THE SIGNAL-REGULATORY PROTEIN ( SIRP) ALPHA DOMAIN REMARK 900 THAT BINDS CD47. REMARK 999 REMARK 999 SEQUENCE REMARK 999 SIRP ALPHA (CHAINS A AND B) RESIDUE NUMBERING IS FOR THE REMARK 999 MATURE PROTEIN (LACKING N-TERMINAL 30 AMINO ACID SIGNAL REMARK 999 SEQUENCE). C-TERMINAL PURIFICATION TAG (TRHHHHHH) IS REMARK 999 ADDED. REMARK 999 CD47 RESIDUE NUMBERING IS FOR MATURE PROTEIN (LACKING N- REMARK 999 TERMINAL 18 AMINO ACID SIGNAL SEQUENCE). RESIDUE 1 (GLN) REMARK 999 CYCLISES TO FORM A PYROGLUTAMIC ACID. RESIDUE 15 WAS REMARK 999 MUTATED FROM CYS TO GLY. C-TERMINAL PURIFICATION TAG ( REMARK 999 STRHHHHHH) IS ADDED. DBREF 2JJT A 1 118 UNP P78324 SHPS1_HUMAN 31 148 DBREF 2JJT A 119 126 PDB 2JJT 2JJT 119 126 DBREF 2JJT B 1 118 UNP P78324 SHPS1_HUMAN 31 148 DBREF 2JJT B 119 126 PDB 2JJT 2JJT 119 126 DBREF 2JJT C 1 118 UNP Q08722 CD47_HUMAN 19 136 DBREF 2JJT C 119 127 PDB 2JJT 2JJT 119 127 DBREF 2JJT D 1 118 UNP Q08722 CD47_HUMAN 19 136 DBREF 2JJT D 119 127 PDB 2JJT 2JJT 119 127 SEQADV 2JJT GLY C 15 UNP Q08722 CYS 33 ENGINEERED MUTATION SEQADV 2JJT GLY D 15 UNP Q08722 CYS 33 ENGINEERED MUTATION SEQRES 1 A 126 GLU GLU GLU LEU GLN VAL ILE GLN PRO ASP LYS SER VAL SEQRES 2 A 126 SER VAL ALA ALA GLY GLU SER ALA ILE LEU HIS CYS THR SEQRES 3 A 126 VAL THR SER LEU ILE PRO VAL GLY PRO ILE GLN TRP PHE SEQRES 4 A 126 ARG GLY ALA GLY PRO ALA ARG GLU LEU ILE TYR ASN GLN SEQRES 5 A 126 LYS GLU GLY HIS PHE PRO ARG VAL THR THR VAL SER GLU SEQRES 6 A 126 SER THR LYS ARG GLU ASN MET ASP PHE SER ILE SER ILE SEQRES 7 A 126 SER ASN ILE THR PRO ALA ASP ALA GLY THR TYR TYR CYS SEQRES 8 A 126 VAL LYS PHE ARG LYS GLY SER PRO ASP THR GLU PHE LYS SEQRES 9 A 126 SER GLY ALA GLY THR GLU LEU SER VAL ARG ALA LYS PRO SEQRES 10 A 126 SER THR ARG HIS HIS HIS HIS HIS HIS SEQRES 1 B 126 GLU GLU GLU LEU GLN VAL ILE GLN PRO ASP LYS SER VAL SEQRES 2 B 126 SER VAL ALA ALA GLY GLU SER ALA ILE LEU HIS CYS THR SEQRES 3 B 126 VAL THR SER LEU ILE PRO VAL GLY PRO ILE GLN TRP PHE SEQRES 4 B 126 ARG GLY ALA GLY PRO ALA ARG GLU LEU ILE TYR ASN GLN SEQRES 5 B 126 LYS GLU GLY HIS PHE PRO ARG VAL THR THR VAL SER GLU SEQRES 6 B 126 SER THR LYS ARG GLU ASN MET ASP PHE SER ILE SER ILE SEQRES 7 B 126 SER ASN ILE THR PRO ALA ASP ALA GLY THR TYR TYR CYS SEQRES 8 B 126 VAL LYS PHE ARG LYS GLY SER PRO ASP THR GLU PHE LYS SEQRES 9 B 126 SER GLY ALA GLY THR GLU LEU SER VAL ARG ALA LYS PRO SEQRES 10 B 126 SER THR ARG HIS HIS HIS HIS HIS HIS SEQRES 1 C 127 PCA LEU LEU PHE ASN LYS THR LYS SER VAL GLU PHE THR SEQRES 2 C 127 PHE GLY ASN ASP THR VAL VAL ILE PRO CYS PHE VAL THR SEQRES 3 C 127 ASN MET GLU ALA GLN ASN THR THR GLU VAL TYR VAL LYS SEQRES 4 C 127 TRP LYS PHE LYS GLY ARG ASP ILE TYR THR PHE ASP GLY SEQRES 5 C 127 ALA LEU ASN LYS SER THR VAL PRO THR ASP PHE SER SER SEQRES 6 C 127 ALA LYS ILE GLU VAL SER GLN LEU LEU LYS GLY ASP ALA SEQRES 7 C 127 SER LEU LYS MET ASP LYS SER ASP ALA VAL SER HIS THR SEQRES 8 C 127 GLY ASN TYR THR CYS GLU VAL THR GLU LEU THR ARG GLU SEQRES 9 C 127 GLY GLU THR ILE ILE GLU LEU LYS TYR ARG VAL VAL SER SEQRES 10 C 127 TRP SER THR ARG HIS HIS HIS HIS HIS HIS SEQRES 1 D 127 PCA LEU LEU PHE ASN LYS THR LYS SER VAL GLU PHE THR SEQRES 2 D 127 PHE GLY ASN ASP THR VAL VAL ILE PRO CYS PHE VAL THR SEQRES 3 D 127 ASN MET GLU ALA GLN ASN THR THR GLU VAL TYR VAL LYS SEQRES 4 D 127 TRP LYS PHE LYS GLY ARG ASP ILE TYR THR PHE ASP GLY SEQRES 5 D 127 ALA LEU ASN LYS SER THR VAL PRO THR ASP PHE SER SER SEQRES 6 D 127 ALA LYS ILE GLU VAL SER GLN LEU LEU LYS GLY ASP ALA SEQRES 7 D 127 SER LEU LYS MET ASP LYS SER ASP ALA VAL SER HIS THR SEQRES 8 D 127 GLY ASN TYR THR CYS GLU VAL THR GLU LEU THR ARG GLU SEQRES 9 D 127 GLY GLU THR ILE ILE GLU LEU LYS TYR ARG VAL VAL SER SEQRES 10 D 127 TRP SER THR ARG HIS HIS HIS HIS HIS HIS MODRES 2JJT ASN C 16 ASN GLYCOSYLATION SITE MODRES 2JJT ASN C 55 ASN GLYCOSYLATION SITE MODRES 2JJT ASN C 93 ASN GLYCOSYLATION SITE MODRES 2JJT ASN D 16 ASN GLYCOSYLATION SITE MODRES 2JJT ASN D 32 ASN GLYCOSYLATION SITE MODRES 2JJT ASN D 93 ASN GLYCOSYLATION SITE MODRES 2JJT PCA C 1 GLU PYROGLUTAMIC ACID MODRES 2JJT PCA D 1 GLU PYROGLUTAMIC ACID HET PCA C 1 8 HET PCA D 1 8 HET NAG C1116 14 HET NAG C1117 14 HET NAG C1118 14 HET NAG D1116 14 HET NAG D1117 14 HET NAG D1118 14 HETNAM PCA PYROGLUTAMIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 PCA 2(C5 H7 N O3) FORMUL 5 NAG 6(C8 H15 N O6) FORMUL 11 HOH *43(H2 O) HELIX 1 1 PRO A 83 ASP A 85 5 3 HELIX 2 2 PRO B 83 ASP B 85 5 3 HELIX 3 6 VAL C 70 LYS C 75 5 6 HELIX 4 7 LYS C 84 VAL C 88 1 5 HELIX 5 10 VAL D 70 LYS D 75 5 6 HELIX 6 11 LYS D 84 VAL D 88 1 5 SHEET 1 AA 2 VAL A 6 ILE A 7 0 SHEET 2 AA 2 THR A 26 VAL A 27 -1 O THR A 26 N ILE A 7 SHEET 1 AB 5 SER A 12 ALA A 16 0 SHEET 2 AB 5 THR A 109 ARG A 114 1 O GLU A 110 N VAL A 13 SHEET 3 AB 5 GLY A 87 ARG A 95 -1 O GLY A 87 N LEU A 111 SHEET 4 AB 5 ILE A 36 ARG A 40 -1 O GLN A 37 N VAL A 92 SHEET 5 AB 5 GLU A 47 TYR A 50 -1 O GLU A 47 N ARG A 40 SHEET 1 AC 4 SER A 12 ALA A 16 0 SHEET 2 AC 4 THR A 109 ARG A 114 1 O GLU A 110 N VAL A 13 SHEET 3 AC 4 GLY A 87 ARG A 95 -1 O GLY A 87 N LEU A 111 SHEET 4 AC 4 THR A 101 SER A 105 -1 O THR A 101 N ARG A 95 SHEET 1 AD 3 ALA A 21 LEU A 23 0 SHEET 2 AD 3 ILE A 76 ILE A 78 -1 O ILE A 76 N LEU A 23 SHEET 3 AD 3 VAL A 60 THR A 62 -1 O THR A 61 N SER A 77 SHEET 1 BA 2 VAL B 6 ILE B 7 0 SHEET 2 BA 2 THR B 26 VAL B 27 -1 O THR B 26 N ILE B 7 SHEET 1 BB 5 SER B 12 ALA B 16 0 SHEET 2 BB 5 THR B 109 ARG B 114 1 O GLU B 110 N VAL B 13 SHEET 3 BB 5 GLY B 87 ARG B 95 -1 O GLY B 87 N LEU B 111 SHEET 4 BB 5 ILE B 36 ARG B 40 -1 O GLN B 37 N VAL B 92 SHEET 5 BB 5 GLU B 47 TYR B 50 -1 O GLU B 47 N ARG B 40 SHEET 1 BC 4 SER B 12 ALA B 16 0 SHEET 2 BC 4 THR B 109 ARG B 114 1 O GLU B 110 N VAL B 13 SHEET 3 BC 4 GLY B 87 ARG B 95 -1 O GLY B 87 N LEU B 111 SHEET 4 BC 4 THR B 101 SER B 105 -1 O THR B 101 N ARG B 95 SHEET 1 BD 3 ALA B 21 LEU B 23 0 SHEET 2 BD 3 ILE B 76 ILE B 78 -1 O ILE B 76 N LEU B 23 SHEET 3 BD 3 VAL B 60 THR B 62 -1 O THR B 61 N SER B 77 SHEET 1 CA 6 SER C 9 PHE C 12 0 SHEET 2 CA 6 ARG C 103 TYR C 113 1 O GLU C 110 N VAL C 10 SHEET 3 CA 6 GLY C 92 GLU C 100 -1 O GLY C 92 N LEU C 111 SHEET 4 CA 6 VAL C 36 PHE C 42 -1 O TYR C 37 N THR C 99 SHEET 5 CA 6 ASP C 46 ASP C 51 -1 N ILE C 47 O TRP C 40 SHEET 6 CA 6 LYS C 56 THR C 58 -1 O LYS C 56 N ASP C 51 SHEET 1 CB 2 THR C 18 ILE C 21 0 SHEET 2 CB 2 LEU C 80 ASP C 83 -1 O LEU C 80 N ILE C 21 SHEET 1 DA 6 SER D 9 PHE D 12 0 SHEET 2 DA 6 ARG D 103 TYR D 113 1 O GLU D 110 N VAL D 10 SHEET 3 DA 6 GLY D 92 GLU D 100 -1 O GLY D 92 N LEU D 111 SHEET 4 DA 6 VAL D 36 PHE D 42 -1 O TYR D 37 N THR D 99 SHEET 5 DA 6 ASP D 46 ASP D 51 -1 N ILE D 47 O TRP D 40 SHEET 6 DA 6 LYS D 56 THR D 58 -1 O LYS D 56 N ASP D 51 SHEET 1 DB 2 THR D 18 ILE D 21 0 SHEET 2 DB 2 LEU D 80 ASP D 83 -1 O LEU D 80 N ILE D 21 SSBOND 1 CYS A 25 CYS A 91 1555 1555 2.02 SSBOND 2 CYS B 25 CYS B 91 1555 1555 2.03 SSBOND 3 CYS C 23 CYS C 96 1555 1555 2.05 SSBOND 4 CYS D 23 CYS D 96 1555 1555 2.04 LINK C PCA C 1 N LEU C 2 1555 1555 1.32 LINK ND2 ASN C 16 C1 NAG C1116 1555 1555 1.45 LINK ND2 ASN C 55 C1 NAG C1117 1555 1555 1.43 LINK ND2 ASN C 93 C1 NAG C1118 1555 1555 1.44 LINK C PCA D 1 N LEU D 2 1555 1555 1.33 LINK ND2 ASN D 16 C1 NAG D1116 1555 1555 1.45 LINK ND2 ASN D 32 C1 NAG D1117 1555 1555 1.44 LINK ND2 ASN D 93 C1 NAG D1118 1555 1555 1.44 CISPEP 1 ILE A 31 PRO A 32 0 2.01 CISPEP 2 GLU A 54 GLY A 55 0 -4.23 CISPEP 3 SER A 98 PRO A 99 0 -3.14 CISPEP 4 ILE B 31 PRO B 32 0 0.62 CISPEP 5 SER B 98 PRO B 99 0 -2.16 CRYST1 53.620 63.720 123.020 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018650 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015694 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008129 0.00000